{
    "id": "7792109",
    "text": "Beximco Pharmaceuticals Ltd also known as Beximco Pharma, is a pharmaceutical company in Bangladesh. It is part of the Beximco Group of Companies. ==Corporate history== Beximco Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of United States. Today Beximco Pharma manufactures and markets its own branded generics for several diseases including AIDS, cancer, asthma, hypertension, and diabetes for both national and international markets. It was the first drug company from Bangladesh to sell its products in the US. In May 2020, the company introduced world\u2019s first generic Remdesivir for Covid-19 treatment. ==Factories== Beximco Pharma manufacturing facilities are spread across a site located in Dhaka, Bangladesh. The facilities consist of a number of purpose-built plants, including a new Oral Solid Dosage (OSD) plant. The site includes manufacturing facilities as well as a research laboratory and a number of warehouses. The plant and machinery of the facilities were designed, produced and installed by partners from Germany, Switzerland, Sweden, Italy and the United Kingdom, amongst others. ==Exports== On August, 2007, Beximco exported its medicines to the Philippines, the 5th country of the 10-member Association of South East Asian Nations (ASEAN) to import Beximco's drugs. Beximco Managing Director Nazmul Hassan said that exports to the Philippines include metered dose inhalers, and nasal sprays, and other medications. The Philippine pharmaceutical market ($1.3 billion in 2007), is highly dependent on imported medicines. Reuters, Bangladesh Beximco exports drugs to Philippines ==References== ==External links== * * * Category:Pharmaceutical companies of Bangladesh Category:Pharmaceutical companies established in 1980 Category:Companies listed on the Dhaka Stock Exchange ",
    "title": "Beximco Pharma"
}